DURAGLAN Tablet Prolonged Release 4mg Base Milligrams Ireland - English - HPRA (Health Products Regulatory Authority)

duraglan tablet prolonged release 4mg base milligrams

jacobsen pharma a/s - doxazosin mesilate - tablet prolonged release - 4mg base milligrams

DURAGLAN 4mg Base Milligrams Tablet Prolonged Release Ireland - English - HPRA (Health Products Regulatory Authority)

duraglan 4mg base milligrams tablet prolonged release

jacobsen pharma a/s - doxazosin mesilate - tablet prolonged release - 4mg base milligrams

Prenoxad 0.91 mg/ml solution for injection in a pre-filled syringe Ireland - English - HPRA (Health Products Regulatory Authority)

prenoxad 0.91 mg/ml solution for injection in a pre-filled syringe

aurum pharmaceutical limited - naloxone hydrochloride dihydrate - solution for injection in pre-filled syringe - 0.91 milligram(s)/millilitre - antidotes; naloxone

SILOCALM 5mg/5 Millilitre Oral Suspension Ireland - English - HPRA (Health Products Regulatory Authority)

silocalm 5mg/5 millilitre oral suspension

jacobsen pharma & medtech advice a/s - clobazam - oral suspension - 5mg/5 millilitre - benzodiazepine derivatives

SILOCALM 10mg/5 Millilitre Oral Suspension Ireland - English - HPRA (Health Products Regulatory Authority)

silocalm 10mg/5 millilitre oral suspension

jacobsen pharma & medtech advice a/s - clobazam - oral suspension - 10mg/5 millilitre - benzodiazepine derivatives

Zurampic European Union - English - EMA (European Medicines Agency)

zurampic

grünenthal gmbh - lesinurad - hyperuricemia - antigout preparations - zurampic, in combination with a xanthine oxidase inhibitor, is indicated in adults for the adjunctive treatment of hyperuricaemia in gout patients (with or without tophi) who have not achieved target serum uric acid levels with an adequate dose of a xanthine oxidase inhibitor alone.,